TIFFANY HENDRIX: Open Payments
NPI 1982945416 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 20 payments from 12 companies in 2025. Trend: 2023 $474 · 2024 $375 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 6 | $109 |
| Sage Therapeutics, LLC | 3 | $57 |
| MILLICENT US INC | 2 | $44 |
| Astellas Pharma US Inc | 1 | $25 |
| CooperSurgical, Inc. | 1 | $24 |
| Exeltis, USA Inc. | 1 | $24 |
| Hologic Sales and Service, LLC | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: ZURZUVAE, FEMLYV, Veozah, Paragard T 380A, SLYND, APTIMA, MYFEMBREE, Cologuard Collection Kit.
Industry payments across NV — which companies pay providers there.
